126 related articles for article (PubMed ID: 37162457)
1. Reversal of HMGA1-Mediated Immunosuppression Synergizes with Immunogenic Magnetothermodynamic for Improved Hepatocellular Carcinoma Therapy.
Yan B; Liu C; Li H; Wen N; Jiao W; Wang S; Zhang Y; Zhang T; Zhang H; Lv Y; Fan H; Liu X
ACS Nano; 2023 May; 17(10):9209-9223. PubMed ID: 37162457
[TBL] [Abstract][Full Text] [Related]
2. Reprogrammed IDO-Induced Immunosuppressive Microenvironment Synergizes with Immunogenic Magnetothermodynamics for Improved Cancer Therapy.
Wang X; Yan B; Li H; Yuan J; Guo J; Wang S; Dai P; Liu X
ACS Appl Mater Interfaces; 2024 Jun; ():. PubMed ID: 38843203
[TBL] [Abstract][Full Text] [Related]
3. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis.
Zhu J; Zheng Y; Liu Y; Chen M; Liu Y; Li J
Medicine (Baltimore); 2023 Jan; 102(4):e32707. PubMed ID: 36705364
[TBL] [Abstract][Full Text] [Related]
4. Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis.
Liu X; Zheng J; Sun W; Zhao X; Li Y; Gong N; Wang Y; Ma X; Zhang T; Zhao LY; Hou Y; Wu Z; Du Y; Fan H; Tian J; Liang XJ
ACS Nano; 2019 Aug; 13(8):8811-8825. PubMed ID: 31328922
[TBL] [Abstract][Full Text] [Related]
5. Nanoenabled Reversal of IDO1-Mediated Immunosuppression Synergizes with Immunogenic Chemotherapy for Improved Cancer Therapy.
Huang H; Jiang CT; Shen S; Liu A; Gan YJ; Tong QS; Chen SB; Gao ZX; Du JZ; Cao J; Wang J
Nano Lett; 2019 Aug; 19(8):5356-5365. PubMed ID: 31286779
[TBL] [Abstract][Full Text] [Related]
6. Graphene Oxide-Grafted Magnetic Nanorings Mediated Magnetothermodynamic Therapy Favoring Reactive Oxygen Species-Related Immune Response for Enhanced Antitumor Efficacy.
Liu X; Yan B; Li Y; Ma X; Jiao W; Shi K; Zhang T; Chen S; He Y; Liang XJ; Fan H
ACS Nano; 2020 Feb; 14(2):1936-1950. PubMed ID: 31961656
[TBL] [Abstract][Full Text] [Related]
7. Effect of surface modification on the distribution of magnetic nanorings in hepatocellular carcinoma and immune cells.
Jiao W; Wen N; Wang S; Zhou G; Lu Q; Su Z; Wang X; Hu S; Xie Y; Zhang N; Liu X
J Mater Chem B; 2024 Mar; 12(10):2628-2638. PubMed ID: 38376513
[TBL] [Abstract][Full Text] [Related]
8. ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1/STAT3 pathway.
Tian Z; Liu Z; Fang X; Cao K; Zhang B; Wu R; Wen X; Wen Q; Shi H; Wang R
Carcinogenesis; 2021 Apr; 42(3):493-506. PubMed ID: 33332531
[TBL] [Abstract][Full Text] [Related]
9. Vitamin k3-Loaded Magnetic Nanoparticle-Mediated Synergistic Magnetothermodynamic Therapy Evokes Massive ROS and Immune Modulation for Augmented Antitumor Potential.
Chauhan A; Anjaly K; Saini A; Kumar R; Kuanr BK; Sharma D
ACS Appl Mater Interfaces; 2023 Jun; 15(23):27515-27532. PubMed ID: 37264797
[TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Cell Oncol (Dordr); 2020 Dec; 43(6):1203-1214. PubMed ID: 32797385
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts induce immunotherapy resistance in hepatocellular carcinoma animal model.
Yu L; Liu Q; Huo J; Wei F; Guo W
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):36-40. PubMed ID: 32415924
[TBL] [Abstract][Full Text] [Related]
12. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
[TBL] [Abstract][Full Text] [Related]
13. HMGA1 Promotes Macrophage Recruitment via Activation of NF-
Chen J; Ji K; Gu L; Fang Y; Pan M; Tian S
J Immunol Res; 2022; 2022():4727198. PubMed ID: 35785026
[TBL] [Abstract][Full Text] [Related]
14. TOX promotes the exhaustion of antitumor CD8
Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
[TBL] [Abstract][Full Text] [Related]
15. Hydrazide-manganese coordinated multifunctional nanoplatform for potentiating immunotherapy in hepatocellular carcinoma.
Hou G; Qian J; Guo M; Xu W; Wang J; Wang Y; Suo A
J Colloid Interface Sci; 2022 Dec; 628(Pt B):968-983. PubMed ID: 36037718
[TBL] [Abstract][Full Text] [Related]
16. The Combined Antitumor Effects of
Zhang J; Wu N; Lian Z; Feng H; Jiang Q; Chen X; Gong J; Qiao Z
Technol Cancer Res Treat; 2017 Dec; 16(6):1083-1091. PubMed ID: 29332456
[TBL] [Abstract][Full Text] [Related]
17. Ferritin Nanocaged Doxorubicin Potentiates Chemo-Immunotherapy against Hepatocellular Carcinoma via Immunogenic Cell Death.
Chen Y; Zeng L; Zhu H; Wu Q; Liu R; Liang Q; Chen B; Dai H; Tang K; Liao C; Huang Y; Yan X; Fan K; Du JZ; Lin R; Wang J
Small Methods; 2023 May; 7(5):e2201086. PubMed ID: 36446639
[TBL] [Abstract][Full Text] [Related]
18. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma.
Sheng H; Huang Y; Xiao Y; Zhu Z; Shen M; Zhou P; Guo Z; Wang J; Wang H; Dai W; Zhang W; Sun J; Cao C
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461345
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression.
Kim M; Lee JS; Kim W; Lee JH; Jun BH; Kim KS; Kim DE
J Control Release; 2022 Aug; 348():893-910. PubMed ID: 35760233
[TBL] [Abstract][Full Text] [Related]
20. Gemcitabine-facilitated modulation of the tumor microenvironment and PD-1/PD-L1 blockade generate a synergistic antitumor effect in a murine hepatocellular carcinoma model.
Wang H; He X; Fang D; Wang X; Guan J; Shi ZW; Chen X
Clin Res Hepatol Gastroenterol; 2022 Apr; 46(4):101853. PubMed ID: 34923183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
